Preventing antimalarial drug resistance through combinations
- 1 March 1998
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 1 (1), 3-9
- https://doi.org/10.1016/s1368-7646(98)80208-2
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Therapeutics and drug developmentThe Lancet, 1997
- Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malariaParasitology Today, 1996
- Interactions of Atovaquone with Other Antimalarial Drugs against Plasmodium falciparum in VitroExperimental Parasitology, 1995
- The mode of action and the mechanism of resistance to antimalarial drugsActa Tropica, 1994
- Pyrimethamine resistant mutations in Plasmodium falciparumMolecular and Biochemical Parasitology, 1992
- Prevalence of the Dihydrofolate Reductase Asn-108 Mutation as the Basis for Pyrimethamine-Resistant Falciparum Malaria in the Brazilian AmazonThe American Journal of Tropical Medicine and Hygiene, 1991
- Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum crossNature, 1990
- Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparumCell, 1989
- Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot studyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- Paludrine resistant falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1949